Vitreous Levels of Luteinizing Hormone and VEGF are Strongly Correlated in Healthy Mammalian Eyes

References

• Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25(4):581–611. doi:10.1210/er.2003-0027.
   PubMed Web of Science ®Google Scholar
• Amadio M, Govoni S, Pascale A. Targeting VEGF in eye neovascularization: what’s new?: a comprehensive review on current therapies and oligonucleotide-based interventions under development. Pharmacol Res. 2016;103:253–69. doi:10.1016/j.phrs.2015.11.027.
   PubMed Web of Science ®Google Scholar
• Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331(22):1480–87. doi:10.1056/NEJM199412013312203.
   PubMed Web of Science ®Google Scholar
• Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Caldwell RW. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev. 2003;19(6):442–55. doi:10.1002/dmrr.415.
   PubMed Web of Science ®Google Scholar
• Semeraro F, Cancarini A, Morescalchi F, Romano M, dellOmo R, Ruggeri G, Agnifili L, Costagliola C. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy. Diabetes Metab. 2014;40(6):445–51. doi:10.1016/j.diabet.2014.04.005.
   PubMed Web of Science ®Google Scholar
• Tarr JM, Kaul K, Chopra M, Kohner EM, Chibber R. Pathophysiology of diabetic retinopathy. ISRN Ophthalmology. 2013; 2013 Jan 15.
   Google Scholar
• Dor Y, Porat R, Keshet E. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. Am J Physiol Cell Physiol. 2001;280(6):C1367–74. doi:10.1152/ajpcell.2001.280.6.C1367.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med. 2003;54:17–28. doi:10.1146/annurev.med.54.101601.152418.
   PubMed Web of Science ®Google Scholar
• Aly H, Hassanein S, Nada A, Mohamed MH, Atef SH, Atiea W. Vascular endothelial growth factor in neonates with perinatal asphyxia. Brain Dev. 2009;31(8):600–04. doi:10.1016/j.braindev.2008.09.004.
   PubMed Web of Science ®Google Scholar
• Baba T, McLeod DS, Edwards MM, Merges C, Sen T, Sinha D, Lutty GA. VEGF 165 b in the developing vasculatures of the fetal human eye. Dev Dyn. 2012;241(3):595–607. doi:10.1002/dvdy.23743.
   PubMed Web of Science ®Google Scholar
• Slomiany MG, Rosenzweig SA. Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion. J Pharmacol Exp Ther. 2006;318(2):666–75. doi:10.1124/jpet.106.104158.
   PubMed Web of Science ®Google Scholar
• Hartnett ME. Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology. 2015;122(1):200–10. doi:10.1016/j.ophtha.2014.07.050.
   PubMed Web of Science ®Google Scholar
• Cheung CY. Vascular endothelial growth factor: possible role in fetal development and placental function. J Soc Gynecol Investig. 1997;4(4):169–77. doi:10.1177/107155769700400401.
   PubMedGoogle Scholar
• Stone J, Itin A, Alon T, Pe’er J, Gnessin H, Chan-Ling T, Keshet E. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15(7 Pt 1):4738–47. doi:10.1523/JNEUROSCI.15-07-04738.1995.
   PubMed Web of Science ®Google Scholar
• Tsampalas M, Gridelet V, Berndt S, Foidart J-M, Geenen V. d’Hauterive SP. Human Chorionic Gonadotropin: Hormone with Immunol Angiogenic Prop J Reprod Immunol. 2010;85(1):93–98.
   Google Scholar
• Licht P, Losch A, Dittrich R, Neuwinger J, Siebzehnrã¼Bl E, Wildt L. Novel insights into human endometrial paracrinology and embryo-maternal communication by intrauterine microdialysis. Hum Reprod Update. 1998;4(5):532–38. doi:10.1093/humupd/4.5.532.
   PubMed Web of Science ®Google Scholar
• Rasmussen K, Laugesen C, Ringholm L, Vestgaard M, Damm P, Mathiesen E. Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes. Diabetologia. 2010;53(6):1076–83. doi:10.1007/s00125-010-1697-9.
   PubMed Web of Science ®Google Scholar
• Babitha V, Yadav VP, Chouhan VS, Hyder I, Dangi SS, Gupta M, Khan FA, Taru-Sharma G, Sarkar M. Luteinizing hormone, insulin like growth factor-1, and epidermal growth factor stimulate vascular endothelial growth factor production in cultured bubaline granulosa cells. Gen Comp Endocrinol. 2014;198:1–12. doi:10.1016/j.ygcen.2013.12.004.
   PubMed Web of Science ®Google Scholar
• Cole LA. Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol. 2010;8(1):102. doi:10.1186/1477-7827-8-102.
   PubMed Web of Science ®Google Scholar
• Trau HA, Davis JS, Duffy DM. Angiogenesis in the primate ovulatory follicle is stimulated by luteinizing hormone via prostaglandin E2. Biol Reprod. 2015;92(1):15. doi:10.1095/biolreprod.114.123711.
   PubMed Web of Science ®Google Scholar
• Chong A, Aw S. Postmortem endocrine levels in the vitreous humor. Ann Acad Med Singapore. 1986;15(4):606–09.
   PubMedGoogle Scholar
• Dukic-Stefanovic S, Walther J, Wosch S, Zimmermann G, Wiedemann P, Alexander H, Claudepierre T. Chorionic gonadotropin and its receptor are both expressed in human retina, possible implications in normal and pathological conditions. PloS One. 2012;7(12):e52567. doi:10.1371/journal.pone.0052567.
   PubMed Web of Science ®Google Scholar
• Thompson DA, Othman MI, Lei Z, Li X, Huang ZH, Eadie DM, Rao CV. Localization of receptors for luteinizing hormone/chorionic gonadotropin in neural retina. Life Sci. 1998;63(12):1057–64. doi:10.1016/S0024-3205(98)00367-1.
   PubMed Web of Science ®Google Scholar
• Thompson DA, Othman MI, Lei Z, Li X, Huang ZH, Eadie DM, Rao CV. Localization of receptors for luteinizing hormone/chorionic gonadotropin in neural retina. Life Sci. 1998;63(12):1057–64. doi:10.1016/S0024-3205(98)00367-1.
   PubMed Web of Science ®Google Scholar
• De Gooyer TE, Stevenson KA, Humphries P, Simpson DA, Gardiner TA, Stitt AW. Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Iovs. 2006;47(12):5561–68.
   PubMed Web of Science ®Google Scholar
• Arden G. The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment. Br J Ophthalmol. 2001;85(3):366–70. doi:10.1136/bjo.85.3.366.
   PubMed Web of Science ®Google Scholar
• Monteiro JP, Santos FM, Rocha AS, Castro-de-Sousa JP, Queiroz JA, Passarinha LA, Tomaz CT. Vitreous humor in the pathologic scope: insights from proteomic approaches. Proteomics Clin Appl. 2015;9(1–2):187–202. doi:10.1002/prca.201400133.
   PubMed Web of Science ®Google Scholar
• Simo-Servat O, Hernandez C, Simo R. Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy. Mediators Inflamm. 2012;2012:872978. doi:10.1155/2012/872978.
   PubMed Web of Science ®Google Scholar
• Levesque BM, Kalish LA, Winston AB, Parad RB, Hernandez-Diaz S, Phillips M, Zolit A, Morey J, Gupta M, Mammoto A, et al. Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity. Neonatology. 2013;104(1):56–64. doi:10.1159/000351040.
   PubMed Web of Science ®Google Scholar
• Sharma RK, Rowe-Rendleman CL. Validation of molecular and genomic biomarkers of retinal drug efficacy: use of ocular fluid sampling to evaluate VEGF. Neurochem Res. 2011;36(4):655–67. doi:10.1007/s11064-010-0328-7.
   PubMed Web of Science ®Google Scholar